G Share Price | Genpact Ltd. Stock Analysis & Recommendation

Q: How big is Genpact Ltd.?

Market Cap: As of Jun 18, Genpact Ltd. has a market capitalization of 7,593.78 million, categorizing it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, Genpact Ltd. reported net sales of 4,848.03 million and a net profit of 527.57 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2,389.61 million and total assets of 4,987.15 million.

Q: What does Genpact Ltd. do?

Overview:Genpact Ltd. is engaged in providing digitally powered business process management and services, operating within the Miscellaneous industry and classified as a mid-cap company.Financial Snapshot:Most recent Net Sales: 1,214 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 131 Million (Quarterly Results - Mar 2025) Market cap: USD 7,593.78 Million (Mid Cap)Key Metrics:P/E: 14.00 Dividend Yield: 154.01% Debt Equity: 0.29 Return on Equity: 21.71% Price to Book: 3.10 Contact Details:Address: Canon's Court, 22 Victoria Street, HAMILTON None: HM 12 Tel: 1 441 2952244 Website: http://www.genpact.com/

Q: Is Genpact Ltd. technically bullish or bearish?

As of 3 October 2025, the technical trend for Genpact Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators such as the MACD on a weekly basis indicating bearish momentum, and moving averages also reflecting a bearish outlook. Bollinger Bands confirm a bearish trend in both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is bullish on the monthly, which contrasts with the overall bearish sentiment. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a 1-week return of -2.51% compared to the S&P 500's 1.09%, and a year-to-date return of -4.28% against the S&P 500's 14.18%.

Q: Is Genpact Ltd. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. has a P/E of 15.81, suggesting that Genpact is positioned competitively within its industry.Despite its fair valuation, Genpact has underperformed against the S&P 500 in various timeframes, particularly over the last three years, where it returned -12.78% compared to the S&P 500's 81.19%. This underperformance may indicate that while the stock is fairly valued, it may not be the best investment opportunity relative to broader market performance.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

499.5 k

Shareholding (Dec 2025)

FII

26.52%

Held by 205 FIIs

DII

17.31%

Held by 69 DIIs

Promoter

7.68%

How big is Genpact Ltd.?

22-Jun-2025

As of Jun 18, Genpact Ltd. has a market capitalization of 7,593.78 million, with net sales of 4,848.03 million and a net profit of 527.57 million over the latest four quarters.

View full answer

What does Genpact Ltd. do?

22-Jun-2025

Genpact Ltd. provides digitally powered business process management and services, classified as a mid-cap company with a market cap of approximately USD 7.59 billion. As of March 2025, it reported net sales of USD 1.21 billion and a net profit of USD 131 million.

View full answer

Who are in the management team of Genpact Ltd.?

22-Jun-2025

As of March 2022, the management team of Genpact Ltd. includes Mr. James Madden (Independent Chairman), Mr. N. Tyagarajan (CEO), and several Independent Directors: Mr. Ajay Agrawal, Ms. Stacey Cartwright, Ms. Laura Conigliaro, and Ms. Carol Lindstrom. They oversee the company's strategic direction and operations.

View full answer

Is Genpact Ltd. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Genpact Ltd. is in a bearish trend, indicated by bearish momentum from the MACD and moving averages, despite a mildly bullish KST signal, and has underperformed the S&P 500 with a year-to-date return of -4.28%.

View full answer

Is Genpact Ltd. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Genpact Ltd. is fairly valued with a P/E ratio of 14 and has underperformed the S&P 500 over the last three years, returning -12.78% compared to the index's 81.19%.

View full answer

Compare Genpact Ltd. with Similar Stocks

TriNet Group, Inc.Medpace Holdings, Inc.WEX, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 19.50%

Company has a low Debt to Equity ratio (avg) at times

Healthy long term growth as Operating profit has grown by an annual rate 10.73%

Positive results in Jun 25

With ROCE of 22.82%, it has a fair valuation with a 2.62 Enterprise value to Capital Employed

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

USD 6,751 Million (Small Cap)

P/E

13.00

Industry P/E

Dividend Yield

182.65%

Debt Equity

0.15

Return on Equity

22.31%

Price to Book

2.65

Revenue and Profits:

Net Sales:

1,319 Million

(Quarterly Results - Dec 2025)

Net Profit:

143 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-10.07%

6 Months

-7.09%

1 Year

-18.25%

2 Years

22.65%

3 Years

-11.9%

4 Years

-0.57%

5 Years

0.7%

Genpact Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.51%

EBIT Growth (5y)

9.52%

EBIT to Interest (avg)

9.29

Debt to EBITDA (avg)

1.38

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

1.25

Tax Ratio

24.16%

Dividend Payout Ratio

21.73%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

19.50%

ROE (avg)

21.97%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.70

EV to EBIT

10.43

EV to EBITDA

9.40

EV to Capital Employed

2.34

EV to Sales

1.56

PEG Ratio

Dividend Yield

171.95%

ROCE (Latest)

22.44%

ROE (Latest)

20.86%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 111 Schemes (48.46%)

Foreign Institutions

Held by 205 Foreign Institutions (26.52%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.10% vs 2.97% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -1.85% vs 9.87% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,319.00",
          "val2": "1,291.90",
          "chgp": "2.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "228.70",
          "val2": "227.20",
          "chgp": "0.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.60",
          "val2": "17.80",
          "chgp": "10.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.30",
          "val2": "-29.50",
          "chgp": "75.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "143.10",
          "val2": "145.80",
          "chgp": "-1.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.30%",
          "val2": "157.40%",
          "chgp": "-0.21%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.60% vs 6.46% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.55% vs -18.63% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,079.30",
          "val2": "4,764.90",
          "chgp": "6.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "863.80",
          "val2": "772.40",
          "chgp": "11.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "72.90",
          "val2": "80.90",
          "chgp": "-9.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-29.60",
          "val2": "-10.30",
          "chgp": "-187.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "552.50",
          "val2": "513.70",
          "chgp": "7.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.20%",
          "val2": "144.10%",
          "chgp": "0.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,319.00

1,291.90

2.10%

Operating Profit (PBDIT) excl Other Income

228.70

227.20

0.66%

Interest

19.60

17.80

10.11%

Exceptional Items

-7.30

-29.50

75.25%

Consolidate Net Profit

143.10

145.80

-1.85%

Operating Profit Margin (Excl OI)

155.30%

157.40%

-0.21%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.10% vs 2.97% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -1.85% vs 9.87% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5,079.30

4,764.90

6.60%

Operating Profit (PBDIT) excl Other Income

863.80

772.40

11.83%

Interest

72.90

80.90

-9.89%

Exceptional Items

-29.60

-10.30

-187.38%

Consolidate Net Profit

552.50

513.70

7.55%

Operating Profit Margin (Excl OI)

153.20%

144.10%

0.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.60% vs 6.46% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 7.55% vs -18.63% in Dec 2024

All Annual Results

Company CV

About Genpact Ltd.

Genpact Ltd.

Miscellaneous

Genpact Limited is engaged in providing digitally powered business process management and services. The Company's segments include Business process outsourcing and Information technology services. The Company offers various vertical activities, which include banking and financial services; capital markets; insurance; consumer goods and retail; life sciences and healthcare; infrastructure, manufacturing and services, and High Tech. In addition to these vertical activities, it also offers analytics and research, collections and customer services, consulting and transformation services, core industry operations services, enterprise application services, finance and accounting (F&A) services, information technology (IT) infrastructure management services, and supply chain and procurement services. The Company also offers data engineering and data-led digital transformation services.

Company Coordinates

Company Details

Canon's Court, 22 Victoria Street , HAMILTON None : HM 12

Tel: 1 441 2952244

http://www.genpact.com/

Registrar Details